(HRTX) Deferred Tax Assets, Valuation Allowance USD 2011 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Heron Therapeutics, Inc. /De/ quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2011 to 2023.
Heron Therapeutics, Inc. /De/ Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $430 M, a 1.65% increase year-over-year.

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$430 M	+$6.96 M	+1.65%	Dec 31, 2023	10-K	2024-03-12
Q4 2022	$423 M	+$45.4 M	+12%	Dec 31, 2022	10-K	2024-03-12
Q4 2021	$377 M	+$51.5 M	+15.8%	Dec 31, 2021	10-K	2023-03-29
Q4 2020	$326 M	+$53.6 M	+19.7%	Dec 31, 2020	10-K	2022-02-28
Q4 2019	$272 M	+$49.5 M	+22.2%	Dec 31, 2019	10-K	2021-02-24
Q4 2018	$223 M	+$50.7 M	+29.5%	Dec 31, 2018	10-K	2020-03-02
Q4 2017	$172 M	+$3.24 M	+1.92%	Dec 31, 2017	10-K	2019-02-22
Q4 2016	$169 M	+$55.2 M	+48.5%	Dec 31, 2016	10-K	2018-02-27
Q4 2015	$114 M	+$40.4 M	+55.2%	Dec 31, 2015	10-K	2017-02-23
Q4 2014	$73.3 M	+$32 M	+77.7%	Dec 31, 2014	10-K	2016-02-19
Q4 2013	$41.2 M	+$22 M	+115%	Dec 31, 2013	10-K	2015-03-13
Q4 2012	$19.2 M	+$8.9 M	+86.4%	Dec 31, 2012	10-K	2014-03-07
Q4 2011	$10.3 M			Dec 31, 2011	10-K	2014-03-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.